The recent federal announcement of a freeze on projects that help states use their Medicaid programs to suit the needs of ...

The biometric process—run by Indian staff—involved standard fingerprinting and a photo. She stressed the importance of ...

Replimune stock was down 76.88% in pre-market trading on Tuesday, following a 1.94% rally yesterday. The company’s shares ...

Fred Alger Management, an investment management company, released its “Alger Mid Cap Focus Fund” second-quarter 2025 investor ...

A CBS/YouGov poll released Sunday found Trump’s approval rating at 42%, with disapproval at 58%. That approval compares with ...

An artificial intelligence agenda formed on the podcasts of Silicon Valley billionaires is now being set into U.S. policy as ...

The S&P 500 edged up 0.06% to close at a record high of 6,309.62 on Tuesday (July 22), marking its 11th record close of 2025.

A human rights tribunal has found that an employer’s failure to provide accommodation for an immunocompromised worker ...

Flight operations across the country are in a confused state as the Nigerian Civil Aviation Authority (NCAA) and domestic ...

Sands Capital, an investment management company, released its “Sands Capital Technology Innovators Fund” Q2 2025 investor ...

Replimune Group, Inc. faces FDA setbacks with RP1, raising financial risks and dilution concerns. Click here to find out why ...

Replimune (REPL) stock in focus as the FDA rejects its lead drug RP1 as part of a combination regimen for melanoma, a type of ...